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he SDF-1
 
 
 
/CXCR4 ligand/chemokine receptor pair is
required for appropriate patterning during ontogeny
 
and stimulates the growth and differentiation of
 
critical cell types. Here, we demonstrate SDF-1
 
 
 
 and CXCR4
 
expression in fetal pancreas. We have found that SDF-1
 
 
 
and its receptor CXCR4 are expressed in islets, also CXCR4
is expressed in and around the proliferating duct epithelium of
the regenerating pancreas of the interferon (IFN) 
 
 
 
–nonobese
diabetic mouse. We show that SDF-1
 
 
 
 stimulates the
phosphorylation of Akt, mitogen-activated protein kinase,
T
 
and Src in pancreatic duct cells. Furthermore, migration
assays indicate a stimulatory effect of SDF-1
 
 
 
 on ductal
cell migration. Importantly, blocking the SDF-1
 
 
 
/CXCR4
axis in IFN
 
 
 
-nonobese diabetic mice resulted in diminished
 
proliferation and increased apoptosis in the pancreatic ductal
cells. Together, these data indicate that the SDF-1
 
 
 
–CXCR4
ligand receptor axis is an obligatory component in the
maintenance of duct cell survival, proliferation, and migration
during pancreatic regeneration.
 
Introduction
 
Chemokines are a superfamily of small secreted proteins
known initially for their role in leukocyte trafficking (Luster,
1998; Gale and McColl, 1999; Rossi and Zlotnik, 2000).
Chemokines have received much attention for their involve-
ment in the regulation of HIV infection, proliferation, and
mobilization of hematopoietic stem cells, fetal development,
and regulation of angiogenesis (Kim and Broxmeyer, 1999).
Although most chemokines and receptors have overlapping
binding specificity with other family members, SDF-1
 
 
 
 and
its receptor CXCR4 bind only each other (Kim and Broxmeyer,
1999). CXCR4 has also been the focus of numerous papers
because it is a coreceptor for the entry of HIV into T cells
(Feng et al., 1996). SDF-1
 
 
 
 is involved in the migration of
hematopoietic cells to the marrow, and hematopoietic
precursors from the bone marrow via the circulation into
peripheral tissues (Aiuti et al., 1997; D’Apuzzo et al., 1997).
A comprehensive study of the expression of SDF-1
 
 
 
 and
CXCR4 from gastrulation to organogenesis in the mouse
embryo provides evidence of the continuous involvement of
the SDF-1
 
 
 
/CXCR4 axis during embryogenesis (McGrath
et al., 1999). Furthermore, disruption of the genes for SDF-1
 
 
 
or its receptor results in late embryonic lethality. Impor-
tantly, the SDF-1
 
 
 
–deficient mouse and the corresponding
CXCR4 mutants are the only known chemokine/chemokine
receptor mutants that display embryonic lethality (Murphy
et al., 2000). Genetically deficient embryos display severe
defects in their gastrointestinal vasculature, cerebellar neuron
migration, cardiac ventricular septal closure, B cell develop-
ment, and hematopoietic bone marrow colonization (Nagasawa
et al., 1996; Ma et al., 1998; Tachibana et al., 1998; Zou et
al., 1998). The extensive consequences observed in different
organ systems in the SDF-1
 
 
 
 and CXCR4 knockout mice
indicate that the SDF-1
 
 
 
–CXCR4 axis is an essential com-
ponent of differentiation of numerous tissues.
The terminal differentiation of the pancreatic endocrine
cells from epithelial progenitor cells occurs during their mi-
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gration from the duct wall into primitive islet-like structures
(Slack, 1995). The process involves the remodeling of the
cell surface and a change in the adhesive properties of these
cells as they migrate (Cirulli et al., 2000). The signals gov-
erning this migration are not fully defined. Based on the
demonstrated involvement of the SDF-1
 
 
 
–CXCR4 pair in
the migration and proliferation of hematopoietic stem cells,
we hypothesized that this ligand–receptor pair may be
important during pancreatic endocrine cell development.
However, because the genetically deficient mice suffer from
widespread midgestational defects, it is difficult to address
the requirement for CXCR4/SDF-1
 
 
 
 during embryonic de-
velopment. Therefore, we sought to determine the role of
CXCR4 ligation during pancreatic islet regeneration.
In transgenic mice in which the cytokine IFN-
 
 
 
 is ex-
pressed under the control of the insulin promoter, the
pancreas displays remarkable ductal hyperplasia and regen-
eration of new islets (Sarvetnick et al., 1988; Gu and Sarvet-
nick, 1993, 1994). Previous work suggests the pancreatic is-
let regeneration proceeds through the same intermediates as
does islet formation during ontogeny (Gu and Sarvetnick,
1993, 1994; Kritzik et al., 1999, 2000). We have found that
spontaneous islet regeneration in the IFN
 
 
 
 transgenic
mouse recapitulates the pancreatic developmental program
in adults (Kritzik et al., 1999, 2000).
In this work, we tested the hypothesis that CXCR4 liga-
tion is required for the differentiation of pancreatic islets
during regeneration. Our results strongly support an essen-
tial role for the SDF-1
 
 
 
–CXCR4 pair during IFN
 
 
 
 induced
pancreatic regeneration.
 
Results
 
Chemokine expression in the IFN
 
 
 
-nonobese diabetic 
(NOD) pancreas
 
The cytokine IFN
 
 
 
 has been shown to induce the expres-
sion of a number of chemokines, specifically IFN-
 
 
 
–induc-
ible protein 10 kD (IP-10), monokine induced by 
 
 
 
 IFN
(MIG), and IFN-inducible T cell 
 
 
 
 chemoattractant in dif-
ferent tissues (Luster et al., 1985; Kaplan et al., 1987; Luster
and Ravetch, 1987; Gottlieb et al., 1988; Ransohoff et al.,
1993; Cassatella et al., 1997; Sauty et al., 1999). We hy-
pothesized that IFN
 
 
 
-induced chemokines may have an ef-
fect on the migration of pancreatic progenitors to their ap-
propriate niche where they could differentiate into the
endocrine cells of the pancreas. To investigate the induction
of chemokines by IFN
 
 
 
 expression in the pancreas, we used
RNase protection assays. The chemokines that were induced
by the IFN
 
 
 
 transgene compared with nontransgenic NOD
mice were: small inducible cytokine A6 (C-10); IP-10; mac-
rophage inflammatory protein (MIP)-2 ; regulated on acti-
vation normal T-cell expressed and secreted (RANTES; Fig.
1 A); MIG; monocyte chemoattractant protein (MCP)-5;
SDF-1
 
 
 
; thymus-derived chemotactic agent 4 (TCA-4); and
small inducible chemokine A 11 (Eotaxin; Fig. 1 B). In the
NOD pancreas, five of the chemokines were detected: C-10,
Figure 1. Chemokine expression in adult regenerating pancreas. (A) The expression of CHK1 group of chemokines in whole pancreas from 
IFN NOD transgenic mice (lane a) and NOD (lane b) controls. RPA probe CHK1 is shown in lane c and gel positions of chemokines are 
indicated with arrows. In the control lane, the probes typically run more slowly than the digested fragments from target RNA due to the presence 
of restriction sites in the samples. The autoradiograph shown is representative of two independent experiments. (B) Expression of CHK2 group 
of chemokines in whole pancreas from IFN NOD transgenic mice (lane a) and NOD (lane b) controls. RNase protection was performed on 
pooled RNA samples from three mice. The RPA probe CHK2 is shown in lane c and gel positions of chemokines are indicated with arrows. 
As in A, a second identical experiment yielded very similar results. 
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MIG, SDF-1
 
 
 
, TCA-4, and Eotaxin. The relative expres-
sion of chemokines in the transgenic mouse pancreas com-
pared with the NOD pancreas is shown in Table I. As de-
termined by densitometry, C-10 expression was elevated
12-fold in the IFN
 
 
 
 transgenic pancreas compared with the
NOD pancreas. The expression of MIG was enhanced ap-
proximately sixfold in the transgenic pancreas. SDF-1
 
 
 
 ex-
pression was elevated threefold, and TCA-4 and Eotaxin
were expressed at five- and fourfold higher levels than in the
NOD pancreas, respectively. Of the CHK2 chemokines ex-
pressed in the IFN
 
 
 
NOD pancreas, MIG was the most
abundant. MIG expression was 
 
 
 
3.5-fold higher than that
of MCP-5 and almost 1.7-fold that of SDF-1
 
 
 
. IP10, C-10,
and RANTES expression were modest compared with the
MIG, MCP-1, and SDF-1
 
 
 
 (the CHK1 samples had to be
exposed for a longer time to be able to detect expression). All
densitometric comparisons were performed by normalizing
the data to the mitochondrial housekeeping gene L32.
 
Chemokine receptor expression in the 
IFN
 
 
 
NOD pancreas
 
Chemokines induce their effects by binding G protein–cou-
pled receptors. We used probes for chemokine receptors to
determine their expression in NOD and IFN
 
 
 
NOD mouse
pancreas. The chemokine receptors induced in the IFN
 
 
 
-
NOD mouse pancreas were CCR6, CCR7, CCR1, CCR3,
CCR5, CXCR5, DARC, CX3CR1, and CXCR4 (Fig. 2, A
and B). In the NOD only CXCR4, CXCR5, and DARC
were detected. The relative expression of the chemokine re-
ceptors in the transgenic pancreas compared with the NOD
pancreas is shown in Table I. In the transgenic pancreas,
CXCR4 and CXC3CR1 were expressed at approximately
fourfold higher levels compared with the NOD pancreas. Of
the CXC group of chemokine receptors, CXCR4 was the
most abundantly expressed in the IFN
 
 
 
NOD regenerating
pancreas (Fig. 2 B). The CX3CR1 receptor was the second
most abundant in this group.
 
Localization of SDF-1
 
 
 
 and CXCR4 expression 
in the pancreas
 
Of the chemokines and chemokine receptors that we found
to be induced by IFN
 
 
 
, the SDF-1
 
 
 
/CXCR4 pair has been
shown to be an important regulator of cell migration, prolif-
eration, and embryonic development. Next, we performed
histological studies to determine whether the immunolocal-
ization of SDF-1
 
 
 
 and CXCR4 was consistent with their in-
volvement in epithelial migration in the transgenic pancreas.
In the NOD mouse pancreas, SDF-1
 
 
 
 and CXCR4 ex-
pression was detected in islets by immunofluorescence (Fig.
3 A). In addition, SDF-1
 
 
 
 expression was confirmed by
Western blot analysis of proteins expressed by isolated pan-
creatic islets (unpublished data). The expression of SDF-1
 
 
 
in NOD mice appeared constitutive because in vitro treat-
ment of the islets by IFN
 
 
 
 (1,000 U/ml) for 24 h did not
augment SDF-1
 
 
 
 expression, as determined by Western
blotting (
 
n
 
 
 
  
 
2; unpublished data). In the IFN
 
 
 
NOD
mouse, SDF-1
 
 
 
 staining was localized to cells within the is-
let mass (Fig. 3, B and C). In the duct epithelium, frequent
cells, which express only CXCR4 (Fig. 3 E, green), and oc-
casional cells, which coexpress CXCR4 and SDF-1
 
 
 
 (Fig. 3
E, yellow), were observed. Thus, the majority of duct cells
express CXCR4, suggesting that these cells may be migrat-
ing toward the SDF-1
 
 
 
 expressing newly forming islets.
 
CXCR4 and SDF-1
 
 
 
 expression in embryonic pancreas
 
We asked whether the expression of the chemokine SDF-1
 
 
 
and its receptor CXCR4 were involved in the development
of islets during embryogenesis. E18 embryos were used as
they display extensive islet neogenesis at this point. Immu-
nostaining of the pancreas from these embryos revealed ex-
pression of SDF-1
 
 
 
 (Fig. 4 A) and CXCR4 (Fig. 4 B) in fe-
tal pancreas. Our results show that SDF-1
 
 
 
 and CXR4 are
localized to primitive islet cell clusters. However, the ducts
are negative for SDF-1
 
 
 
 expression (Fig. 4 A) while they dis-
 
Table I. 
 
Chemokine and chemokine receptor induction by the IFN
 
 
 
 
transgene in the NOD mouse pancreas
Chemokines NOD IFN
 
 
 
NOD
 
C-10 1 12X
MIG 1 6X
SDF-1
 
 
 
13 X
TCA-4 1 5X
Eotaxin 1 4X
Chemokine receptors
CXCR4 1 4X
CXCR5 1 2.5X
DARC 1 2.5X
Figure 2. Expression of chemokine receptors in adult regenerating 
pancreas. (A) Expression of CCR group of chemokine receptors in 
whole pancreas from IFN NOD transgenic mice (lane a) and NOD 
(lane b) controls. The RPA probe for CCR is shown in lane c. (B) 
Expression of CXCR group of chemokine receptors in IFN NOD 
(lane a) and NOD (lane b) pancreas was determined as described in A. 
The RPA probe for CXCR is shown in lane c. As with the chemokine 
expression experiments a second experiment yielded similar findings. 
Gel positions of chemokine receptors are indicated with arrows. 
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play CXCR4 (Fig. 4 B) expression. In the embryonic pan-
creas, both SDF-1
 
 
 
 (Fig. 4 C, green) and CXCR4 (Fig. 4 D,
green) were found to be frequently coexpressed with insulin
(red). CXCR4 staining was often adjacent to insulin express-
ing cell clusters (Fig. 4 D). Double immunofluorescent
staining of CXCR4 and SDF-1
 
 
 
 (Fig. 4, E and F) revealed
that some cells in the primitive islet structures express SDF-
1
 
 
 
 (red) and duct cells expressed CXCR4 (Fig. 4, D and E,
green). However, the two were often colocalized, suggesting
that this chemokine may be involved in the recruitment of
cells from ducts into the developing islet cell clusters.
 
In vitro stimulation of cell migration by SDF-1
 
 
 
To test the hypothesis that SDF-1
 
 
 
 can stimulate the migra-
tion of ductal progenitor cells of the regenerating pancreas,
we performed in vitro migration assays using cells isolated
from the pancreatic ductal network of regenerating IFN
 
 
 
-
NOD.
 
scid
 
 mice. We measured the effect of SDF-1
 
 
 
 on the
migration of these cells using native or type 1 collagen–
coated membrane inserts. Interestingly, the stimulatory ef-
fect of SDF-1
 
 
 
 was most pronounced in the absence of col-
lagen. 100 and 300 ng/ml of SDF-1
 
 
 
 enhanced duct cell
migration by 52 and 93% (P   0.02), respectively. In the
presence of collagen, chemotaxis was increased by  38% at
both 100 and 300 ng/ml concentrations of SDF-1  (P  
0.001; Fig. 5 A). Interestingly, collagen coating of the inserts
greatly enhanced the apparent basal and SDF-1  induced
migration of the ductal cells (Fig. 5, D and E). This could be
because the freshly isolated cells exhibit increased survival in
the presence of the matrix coating. Alternatively, collagen
may increase the adhesion of these cells, accounting for the
reduced ability of SDF-1  to induce chemotaxis. Together,
the data demonstrate that ductal cells from the regenerating
pancreas migrate in response to SDF-1  and their migration
in vitro is clearly modulated by the presence of ECM.
Effect of CXCR4 neutralization on ductal cell 
proliferation in the IFN NOD pancreas
We have hypothesized that cell migration is critical for the
regenerative process to occur. Because we observed the
CXCR4 receptor induced in the expanding epithelium of
the transgenic pancreas, and because in vitro studies demon-
strated the ability of SDF-1  to induce transgenic ductal cell
migration, we asked whether this receptor–ligand interaction
participated in the regenerative process. Therefore, we deter-
mined the outcome of blocking SDF-1  binding by treating
the IFN  transgenic mice with a CXCR4 neutralizing anti-
body (Gonzalo et al., 2000). For this analysis, two groups of
12-wk-old IFN NOD mice were intravenously treated with
20  g/mouse CXCR4 blocking antibody (n   8) or rabbit
IgG (n   7) every third day for 2 wk. Normally, 12-wk-old
transgenic mice display strong proliferative activity, as evi-
denced by BrdU incorporation, with the development of
elaborate ducts and formation of new islets in the pancreas
(Gu and Sarvetnick, 1993). We stained sections from differ-
ent levels of the pancreas of each mouse and counted the
BrdU-positive duct cells, as well as the total number of duct
cells. The CXCR4 antibody treatment resulted in a 42% de-
Figure 3. SDF-1  and CXCR4 colocalize in the islets of NOD and IFN NOD pancreas. Panel A depicts a confocal image of NOD islet stained 
with SDF-1  (red) and CXCR4 (green) antibodies. Panel B shows SDF-1  and CXCR4 staining in an area of ductal proliferation and islet 
formation in the IFN NOD pancreas. The central region of B which comprises the islet mass is magnified in C. Note that several islet cells 
exhibit SDF-1  (red) expression; others exhibit CXCR4 (green) expression, whereas the majority of cells exhibit double staining (yellow). 
A second region of ductal proliferation is shown in D. A prominent ductal region shown in the square is magnified in E. Most of the ductal 
cells in this region stain for CXCR4 only, with several of the cells exhibiting colocalization of CXCR4 and SDF-1 . Panel F shows nuclear 
staining (blue) of the region in E, confirming its ductal morphology (d, duct; i, islet). Bars, 25  m.SDF-1 /CXCR4 in pancreatic regeneration | Kayali et al. 863
crease in the ratio of BrdU labeled duct cells to the total
number of duct cells in the IFN NOD pancreas compared
with IgG-treated control mice (CXCR4   19.8%; IgG con-
trols   11.41%; Fig. 6). This significant (P   0.005) de-
crease in the proportion of BrdU-positive duct cells indicates
that the SDF-1 /CXCR4 axis has a critical role in the net
expansion of the regenerating duct epithelium.
The effect of CXCR4 neutralization on survival 
in IFN NOD pancreata
Remodeling and directed movement of tissue in development
involves regulation of both cell proliferation and programmed
cell death (Zakeri and Lockshin, 2002). Apoptotic cell death
has also been demonstrated to be involved in the homeostatic
regulation of hematopoiesis (Peters et al., 1998). Indeed, the
Figure 4.  SDF-1a and CXCR4 expression in embryonic NOD pancreas. Panel A illustrates SDF-1  expression by DAB staining in primitive 
islet structures in the fetal pancreas. Ductal areas are clear of SDF-1  staining. Panel B depicts CXCR4 expression in primitive islets and also 
in some ductal cells (d, duct; i, islet). (C) Representative double immunofluorescent images of SDF-1  (green) and insulin (red) reveal extensive 
colocalization (yellow) in the E18 pancreas with a population of cells expressing SDF-1  alone. (D) Insulin (red) and CXCR4 (green) immuno-
fluorescent staining demonstrating that some cells display coexpression of CXCR4 and insulin (yellow), with a significant number of cells 
staining only for CXCR4. (E) Double immunofluorescent staining of CXCR4 (green) and SDF1-  (red) demonstrates that contiguous cells in the 
primitive islet clusters can express the ligand, the receptor, or both (yellow). (F) A ductal region surrounded by developing islet clusters 
magnified from E. Arrows point to duct cells. Bars, 25  m.
Figure 5. SDF-1  stimulates in vitro migration of pancreatic ductal 
cells. (A) Cell migration was measured in the presence and absence 
of collagen coating. Each bar represents either basal migration or 
fold stimulation from basal in a total of six membranes from three 
experiments (mean   SEM); P   0.02 for migration on native mem-
branes and P   0.001 on collagen-treated membranes by analysis 
of variance. B and C are two representative fields of (B) basal and 
(C) SDF-1 –stimulated (300 ng/ml each) ductal cells on uncoated 
membranes. D and E depict two fields of (D) basal and (E) SDF-1 –
stimulated ductal cells migrating on collagen I–coated membranes.864 The Journal of Cell Biology | Volume 163, Number 4, 2003
decreased incorporation of BrdU in the CXCR4-treated mice
could reflect either decreased duct cell replication or increased
turnover of the duct cell population. Therefore, we decided to
assess cell turnover by measuring apoptosis in the pancreatic
epithelial duct cells, quantitating fragmented DNA using the
TUNEL method in the CXCR4 antibody–treated and con-
trol IgG–treated mice. Treatment of IFN NOD transgenic
mice with the CXCR4 blocking antibody resulted in a four-
fold increase in the number of pancreatic ductal nuclei dis-
playing fragmentation (2.0%; P   0.003; Fig. 7). The num-
ber of duct cells undergoing apoptosis was 0.5% in control
IFN NOD mice treated with rabbit IgG. Our results dem-
onstrate a destabilizing effect of blocking CXCR4–SDF-1 
interactions on the survival of duct cells in vivo.
The effect of CXCR4 neutralization on the proportion 
of pancreatic progenitors present in ductal cells
We postulated that the decline in ductal cell replication, and
augmentation in apoptosis in response to CXCR4 neutraliz-
ing antibody could affect the proportion of pancreatic pro-
genitor cells in the regenerating pancreas. The pdx1 gene is a
key regulator of pancreatic development and insulin expres-
sion on   cells (Jonsson et al., 1994; Offield et al., 1996).
We have demonstrated previously that the proliferating
ducts in the IFN  transgenic mouse pancreas express pan-
creatic duodenal homeobox 1 (PDX1; Kritzik et al., 1999).
Treatment with the CXCR4 neutralizing antibody (n   4)
led to a 50% decrease in the number of ductal cells express-
ing PDX1 compared with IgG-treated controls (n   4; P  
0.03; Fig. 8). These results suggest that the SDF-1 –
CXCR4 interaction may be affecting the size of the pop-
ulation of ductal cells that could differentiate into insu-
lin-producing cells. Interestingly, the inhibition of the
SDF-1 –CXCR4 axis impacted the average diameter of
ducts. Although the actual number of duct cells in the treat-
ment and control groups were not statistically significantly
different (not depicted), the number of duct cells residing in
smaller ducts were increased significantly in the CXCR4-
treated group (n   7) compared with IgG-treated controls
(n   7; P   0.001; Fig. 9). These data are consistent with a
role for SDF-1  and CXCR4 in the initiation of expansion
and recruitment to facilitate islet differentiation.
Stimulation of freshly isolated ductal cells with SDF-1  
induces tyrosine phosphorylation of Src, MAPK, and 
Akt (protein kinase B)
SDF-1  has been shown to transduce its actions by bind-
ing its G protein–coupled seven transmembrane receptor
CXCR4 and activating p44/42 MAPK, PI3-Kinase, and Akt
(Ganju et al., 1998; Majka et al., 2000; Vlahakis et al., 2002;
Figure 6. CXCR4 neutralizing antibody treatment diminishes BrdU 
incorporation in the regenerating pancreatic duct cells of the 
IFN NOD mouse. The ratio of BrdU-positive ductal cells to the total 
number of ductal cells is expressed as a mean percentage   SEM 
(P   0.005).
Figure 7. CXCR4 neutralization increases apoptosis in the pancreatic 
duct cells of the IFN NOD mouse. Sections from the pancreas of 
two mice each from the CXCR4 antibody–treated and control groups 
were assessed for apoptosis using the TUNEL method. The number 
of apoptotic nuclei was quantitated as a percentage of the total 
number of duct cells in the pancreas. Values are expressed as
mean   SEM (P   0.003).
Figure 8. CXCR4 neutralization causes reduced numbers of PDX1-
positive progenitor cells within the ductal cell population in the 
IFN NOD pancreas. Sections from the pancreas of four mice each 
from the CXCR4 antibody treatment and control groups were assessed 
for PDX1 expression. Values are expressed as mean   SEM (P   0.03).
Figure 9. Disruption of the CXCR4 SDF-1  axis shifts the distribution 
of the duct cell population into smaller ducts. Hematoxylin stained 
sections from BOUIN’s fixed pancreas from CXCR4 neutralizing 
antibody (n   7) or rabbit IgG (n   7) were scored for ductal cells. 
Values are expressed as mean   SEM (P   0.001).SDF-1 /CXCR4 in pancreatic regeneration | Kayali et al. 865
Floridi et al., 2003). The Src family of tyrosine kinases have
been have been reported to be involved in the activation of
migration in different cell types (Datta et al., 1997; Coffer et
al., 1998; Lowell and Berton, 1998; O’Laughlin-Bunner et
al., 2001; Inngjerdingen et al., 2002). Therefore, we wanted
to determine if SDF-1  could stimulate the phosphorylation
of MAPK, Akt, or Src, signaling proteins that are potentially
associated with the proliferation, survival, or migration of
ductal cells. Cells isolated from the pancreatic ducts of IFN -
NOD mice were serum-starved overnight, and stimulated
with 100 or 300 ng/ml of SDF-1  or 10 ng/ml of EGF for 5
min. Fig. 10 A shows SDF-1  and EGF-stimulated phos-
phorylation of Src, MAPK, and Akt in vitro. EGF-stimulated
MAPK and Akt phosphorylation in these cells. SDF-1 –
stimulated Src phosphorylation about twofold at 300 ng/ml,
where we observed a striking effect of the chemokine on mi-
gration. Our findings suggest a potential role for Src in the
regulation of migration by SDF-1  in the duct progenitor
cells of the regenerating pancreas.
The time courses of stimulation of the phosphorylation of
signaling proteins vary depending on the specific ligand.
Therefore, we examined the time courses of SDF-1  stimu-
lation of MAPK and Akt phosphorylation in freshly isolated
ductal cells. Cells were isolated and serum-starved overnight
as indicated in the previous paragaph, and stimulated with
300 ng/ml SDF-1  for 0, 2, 5, 10, 30 or 60 min. Fig. 10 B
shows the time course of the phosphorylation of MAPK
(p42, p44 ERK1, and ERK2) and Akt. SDF-1 –stimulated
ERK1 and ERK2 phosphorylation was first seen at 2 min
and reached a peak at  10 min. The stimulation of Akt
phosphorylation by SDF-1  was not evident until 10 min,
at which point it was very potent ( 30-fold by densitome-
try). The dramatic phosphorylation of Akt and to a lesser ex-
tent MAPK and Src, in response to SDF-1  in duct cells of
the IFN NOD transgenic mice, indicate a potential in-
volvement of these signaling proteins in the regulation of
migration, proliferation, and survival of the pancreatic pro-
genitor population.
Discussion
Our focus was to identify chemokines that are involved in
cell migration within the regenerating pancreas. SDF-1 
and CXCR4 expression, as determined by RNase protection
Figure 10. SDF-1  stimulates Src, Akt, and MAPK phos-
phorylation in pancreatic duct cells. (A) SDF-1  stimulates 
Src phosphorylation in the pancreatic duct cells of the 
IFN NOD mouse. Cells were stimulated with 100 or 300 
ng/ml SDF-1  or 10 ng/ml EGF for 5 min at 37 C. Whole 
cell lysates were immunoblotted with antibodies to phos-
pho-Src, phospho-MAPK, and phospho-Akt. The blots 
were stripped and reblotted with antiactin antibody to 
confirm equal protein loading. (B) Time course for SDF-1 –
stimulated phosphorylation of MAPK (ERK1 and ERK2) 
and Akt in pancreatic duct cells of the IFN NOD mouse. 
Cells were treated with 300 ng/ml SDF-1  at 37 C for 0, 2, 
5, 10, 30, and 60 min. Whole cell lysates were immuno-
blotted with antibodies to phospho-MAPK and phospho-Akt.866 The Journal of Cell Biology | Volume 163, Number 4, 2003
assays, were greatly enhanced in the IFN NOD mouse pan-
creas. Our experiments revealed expression of this chemo-
kine–chemokine receptor pair in the regenerating IFN -
NOD pancreas and in the developing islet clusters of NOD
embryos. In vivo blocking experiments demonstrated that
the CXCR4 receptor is an obligatory component of pancre-
atic regeneration. A concomitant augmentation in apoptosis
in response to CXCR4 antibody treatment indicated that an
antiapoptotic effect of CXCR4 ligation in the ductal epithe-
lial cells is a component of the enhanced ductal expansion in
the regenerating pancreas. Furthermore, we report a direct
stimulatory effect of SDF-1  on the migration of cells iso-
lated from the ducts of the regenerating adult pancreas.
Therefore, our data suggests that the IFN  induced eleva-
tion in the expression of SDF-1  in the duct epithelium of
the pancreas results in the chemotactic migration of CXCR4
expressing cells, in response to the SDF-1  gradient.
Importantly, neutralization with CXCR4 antibody elicited
a fourfold increase in the proportion of apoptotic ductal cells.
The role of CXCR4 in the regulation of apoptosis is context
dependent. CXCR4 involvement in the stimulation of apop-
tosis by HIV envelope proteins in CD4  T cells has been an
area of extensive study (Herbein et al., 1998; Biard-Piecha-
czyk et al., 1999; Colamussi et al., 2001; Yao et al., 2001;
Arthos et al., 2002). Similarly, CXCR4 regulation of the ap-
optotic effect of HIV coat proteins on neurons of the neocortex
has also been reported (Corasaniti et al., 2001). In contrast,
SDF-1  has been reported to promote survival by inhibiting
apoptosis in hematopoietic progenitor cells (Lataillade et al.,
2002). Furthermore, in fetal thymus organ culture, SDF-1 
enhanced viability of serum-depleted cells in culture by down-
regulating the pro-apoptotic bax protein and up-regulating
the antiapoptotic bcl-2 protein (Hernandez-Lopez et al.,
2002). Interestingly, transgenic mice expressing SDF-1  un-
der a Rous sarcoma virus promoter display enhanced spleen
and bone marrow myelopoiesis in vivo (Broxmeyer et al.,
2003). Myeloid progenitors from the SDF-1  transgenic
mice also exhibit prolonged survival in the absence of growth
factors in vitro compared with progenitors from wild-type
mice. In our pancreatic regeneration model, it appears that
blocking the CXCR4 receptor resulted in an augmentation of
apoptosis, indicating a role for the CXCR4 receptor in pro-
moting survival of the ductal cell precursor pool in the regen-
erating ducts, similar to its role in hematopoietic progenitor
cells. Our observation of diminished numbers of ductal cells
expressing PDX1, a critical pancreatic progenitor marker, in
mice treated with CXCR4 neutralizing antibody is consistent
with the concurrent enhanced programmed cell death.
The endocrine progenitor cells in the ductal epithelium of
the IFN NOD pancreas display primitive cell markers (un-
published data), and may be migrating in response to local
changes in SDF-1  concentration and variations in CXCR4
expression in the cells in response to the cytokine IFN . Once
recruited to a niche where growth factors stimulate their pro-
liferation and differentiation, these progenitors assume an en-
docrine cell lineage. The stimulatory effect of SDF-1  on the
migration of CD34  hematopoietic progenitor cells was es-
tablished relatively early (Aiuti et al., 1997; Kim and Broxm-
eyer, 1998; Mohle et al., 1998). Of the many chemokines as-
sayed SDF-1  was the first to have been shown to affect
directed movement of myeloid progenitor cells (Broxmeyer et
al., 1999). Wright et al. (2002) have reported recently that a
purified population of hematopoietic stem cells expresses
CXCR4 and migrates in response to SDF-1  in vitro. The
mobilization of stem cells in and out of the bone marrow is
important in therapeutic transplant procedures. However,
what is more intriguing is whether these hematopoietic stem
cells can migrate to sites of inflammation and differentiate
into other tissue cell types (Krause et al., 2001). In vivo, SDF-
1  is produced by bone marrow (Bleul et al., 1996) and the
epithelial cells in many organs such as lung (Aiuti et al.,
1997). Two recent papers provide evidence of CXCR4 ex-
pression in epithelial colon cells (Dwinell et al., 1999; Jordan
et al., 1999). Interestingly, another class of cells of epithelial
origin that express CXCR4 receptors are breast cancer cells,
both primary and metastatic (Muller et al., 2001). Further-
more, using neutralizing antibodies for CXCR4 resulted in a
significant reduction in metastatic ability indicating a clear ef-
fect of CXCR4 in the migration of breast cancer cells.
We present evidence that Src, MAPK, or Akt phosphory-
lation may potentially be involved in the stimulation of mi-
gration of the ductal cells by SDF-1 . In vitro stimulation
of the freshly isolated ductal cells with SDF-1  resulted in
the phosphorylation of MAPK and Akt. The robust SDF-1 
effect on Akt phosphorylation coupled with the in vivo re-
sults of an augmentation of apoptosis with CXCR4 neutral-
ization suggests an involvement of Akt in the promotion of
survival of duct cells. Therefore, it is possible for SDF-1  to
have a direct effect on proliferation and survival. Alterna-
tively, CXCR4 expression might induce migration of pro-
genitor cells to niches where they can be stimulated to pro-
liferate, and subsequently, differentiate into endocrine cells.
Importantly, we have shown previously that inhibition of
the infiltration of macrophages did not play a role in the ob-
served proliferation and islet regeneration in the IFN  trans-
genic mice (Gu et al., 1995).
In the current paper, we report the limited expression of
the chemokines C-10, MIG, TCA-4, Eotaxin, and SDF-1 
in the 8-wk-old NOD pancreas. We had reported previously
low level C-10 expression in the 10-wk-old NOD mouse
pancreas (Bradley et al., 1999). In this earlier paper, Th1
cells harvested from primary cultures expressed high levels of
lymphotactin, MIP-1 , MIP-1 , and MCP-1, and low lev-
els of IP-10 and RANTES, when stimulated with anti-CD3.
In addition, Chen et al. (2001) have reported the expression
of MCP-1 in pancreatic islets isolated from NOD mice at
the peak of insulitis (8–10 wk) using RT-PCR; and Cam-
eron et al. (2000) observed a progressive increase in MIP-1 
production by the NOD pancreas peaking at 5 wk, and
MCP-1 expression starting to rise by 10 wk. In the latter pa-
per, chemokine expression was measured by ELISA. The dis-
crepancies in the findings by different investigators may re-
flect differences in the time course of insulitis progression in
the NOD mice, methods used to measure expression of the
chemokines, and the genders of the NOD mice. Further-
more, as the analysis of whole pancreas RNA clearly masks
important local differences in chemokine and chemokine re-
ceptor expression, the localization and potential significance
of chemokines both in the pathogenesis of diabetes and islet
regeneration still remain challenging fields of study.SDF-1 /CXCR4 in pancreatic regeneration | Kayali et al. 867
In conclusion, this paper provides in vivo evidence for a
role of the SDF-1 –CXCR4 chemotaxis axis in a model of
tissue regeneration. Importantly, elucidating the molecular
mechanisms involved in the stimulation of migration and
proliferation and the diminution of apoptosis in the epithe-
lial precursor cells in the regenerating pancreas will help de-
vise effective means for islet replacement in the future.
Materials and methods
Mice
The transgenic mice expressing IFN  in the pancreatic   cells have been de-
scribed previously (Gu and Sarvetnick, 1993, 1994; Sarvetnick et al., 1988,
1990). The IFN  transgenic mice used in the present work were on the NOD
and NOD.scid background (Makino et al., 1980; Prochazka et al., 1992).
The NOD background provides an excellent model for type 1 diabetes.
RNase protection assays
Total RNA was extracted from pancreata from 8-wk-old male IFN NOD
and NOD mice using an RNeasy Kit (QIAGEN) according to the manufac-
turer’s instructions. Pancreatic RNA was pooled from three IFN NOD
transgenic mice and three NOD mice for the RNase protection assays. This
process was repeated two independent times. In-house chemokine and
chemokine receptor probes were used to perform the RNase protection as-
says as described previously (Asensio and Campbell, 1997; Boztug et al.,
2002). The CHK1 chemokine probe detects lymphotactin, C-10, MIP-2,
MCP-3, MIP-1 , T cell activation gene 3, MCP-1, IP-10, MIP-1 , and
RANTES. The CHK2 probe detects MIG, MCP-5, SDF-1 , TCA-4, growth-
regulated oncogene  , Eotaxin, lipopolysaccharide-induced CXC chemo-
kine, IFN-inducible T cell   chemoattractant, and Fractalkine. The probe
for the CCR group of chemokine receptors included CCR6, CCR7, CCR8,
CCR9, CCR4, CCR3, CCR1, CCR5, and CCR2. The probe for the CXCR
group of receptors included CXCR4, CXCR2, CXCR5, DARC, CXCR1,
CXCR3, and CX3CR1. Autoradiographs were analyzed by densitometry us-
ing NIH Image 1.63 for quantitation.
Immunohistochemistry and immunofluorescence
Pancreata from IFN NOD transgenic, NOD mice, and E18 NOD embryos
were fixed in 10% neutral buffered formalin and embedded in paraffin.
Paraffin embedded tissue was cut into 4- m sections and stained using
rabbit polyclonal anti–SDF-1  antibody against mouse SDF-1  (Cell Sci-
ences), goat polyclonal anti-CXCR4 antibody raised against the NH2-termi-
nal extracellular domain of mouse CXCR4 receptor (Capralogics Inc.), or
guinea pig antibody against insulin (DakoCytomation). Slides were coun-
terstained with hematoxylin. For double immunofluorescent detection,
biotinylated secondary goat, rabbit, and guinea pig antibodies (Vector Lab-
oratories) were used, followed by streptavidin-conjugated Alexa Fluor 488
and 568 (Molecular Probes Inc.). The first streptavidin-conjugated Alexa
Fluor (488) incubation was followed by avidin and biotin blocking (Vector
Laboratories). After the Alexa Fluor (568) incubation, the sections were
placed in mounting medium from The Slowfade Light Antifade Kit (Molec-
ular Probes Inc.). Nuclei were visualized with TOPRO3 (Molecular Probes
Inc.). Sections were analyzed on a scanning confocal microscope (model
MRC 1024; BioRad Laboratories), mounted on an Axiovert TV-100 with 40
or 63X objectives (Carl Zeiss MicroImaging, Inc.).
Pancreatic ductal cell purification and islet isolation
Cells of the pancreatic ductal network were purified from 10- to 12-wk-old
IFN NOD.scid mice for the migration experiments and IFN NOD mice
for the assessment of in vitro phosphorylation of signaling proteins. The
pancreata were collagenase (1 mg/ml; Roche) digested for 45 min. The di-
gest was filtered through a 200- m mesh and the ductal network above
the mesh was treated with 0.05% trypsin, 0.53 mM EDTA. The resulting
cell suspension was filtered through a 70- m cell strainer. The cells in the
filtrate were resuspended in RPMI medium. Approximately one million
duct cells were derived from each pancreas preparation. The viability of
these duct cells ranges from 75 to 95%. Pancreatic islets were isolated and
cultured as described previously (Flodstrom et al., 2002).
Migration assays
Chemotaxis was assessed using uncoated or collagen-coated culture plate in-
serts (12- m pore; 12-mm diam; Millipore) placed into 24-well plates. Half
the inserts were coated with 3.48 mg/ml collagen type I (BD Biosciences), di-
luted threefold with 95% ethanol, 2 h at RT, and blocked with 1% BSA.
Freshly isolated ductal network cells resuspended in serum-free RPMI 1640
medium (200,000 cells in 200  l) were added to the upper chambers. 600  l
of RPMI 1640 medium with 0, 100, or 300 ng/ml of SDF-1  (PeproTech) was
added to the bottom chambers and the cells were allowed to migrate for 24 h
at 37 C. At the end of the assay, the cells from the upper chamber were aspi-
rated and the membranes were fixed in 10% neutral buffered formalin,
stained with hematoxylin and eosin, and mounted on slides upside down. Im-
ages of eight fields were captured from each membrane (at a magnification of
20) and the number of cells in or associated with the pores was counted.
Experimental protocol for the CXCR4 antibody neutralization study
12-wk-old IFN NOD mice were divided into two groups of eight. Rabbit
IgG or a rabbit polyclonal CXCR4 neutralizing antibody (20  g/mouse;
Gonzalo et al., 2000; Millennium Pharmaceuticals, Inc.) was injected in-
travenously every third day for a period of 2 wk. The total number of injec-
tions per mouse was five. On day 13 of treatment, 100  g/g BrdU (Sigma-
Aldrich) was administered intraperitoneally. 15 h after the BrdU injection,
pancreatic tissue was fixed in BOUIN’s. Monoclonal rat anti-BrdU anti-
body (Accurate Chemical) was used to assess proliferation.
In pancreata from a subgroup of mice (n   2 per group) treated with
CXCR4 neutralizing antibody or control IgG, TUNEL staining was per-
formed using the in situ cell death detection POD kit (Roche) according to
the manufacturer’s instructions. TUNEL staining was repeated on sections
from two different levels of the pancreas for each animal.
Pancreata from mice treated with IgG or CXCR4 neutralizing antibody
(n   4 per group) were evaluated for PDX1 staining using rabbit polyclonal
anti-PDX1 antibody (CHEMICON International, Inc.). Images were cap-
tured from at least six ductal areas from each mouse and the PDX1-posi-
tive duct cell number and the total duct cell number in these areas were
quantified. In seven of the mice from each group, the percentage of small
ducts (defined as ducts comprising  15 cells) and large ducts were quanti-
fied by counting duct cells from at least 10 images captured from one he-
matoxylin stained section from each mouse.
Assessment of SDF-1 –stimulated Src, MAPK, 
and Akt phosphorylation
Freshly isolated cells from the pancreatic ductal network from IFN NOD
transgenic mice were serum-starved overnight, and stimulated with 100 or
300 ng/ml SDF-1  or 10 ng/ml EGF for 5 min at 37 C. Cells were lysed with
RIPA buffer containing 20 mmol/liter Tris, pH 7.5, 1 mmol/liter EDTA, 140
mmol/liter NaCl, 1% NP-40, 1 mmol/liter orthovanadate, 1 mmol/liter
PMSF, and 10  g/ml aprotinin. Cell lysates were prepared for Western blot
analysis. Rabbit polyclonal antibodies to phospho-Src (Tyr 416), dually
phosphorylated phospho-MAPK (Thr202/Tyr204), and phospho-Akt (Ser473)
were used for immunodetection (Cell Signaling Technology). In a second
stimulation experiment, the cells were isolated and serum starved as above
and treated with 300 ng/ml SDF-1  for 0, 2, 5, 10, 30, and 60 min.
Pancreatic islets were precultured for 5–6 d before a 24-h exposure to
1,000 U/ml IFN  (BD Biosciences) or vehicle. After exposure, the islets
were homogenized in RIPA buffer, and lysates prepared for Western blot
analysis and were immunoblotted with SDF-1  antibody. All membranes
were stripped and reblotted with a mouse mAb to actin to confirm equal
protein loading (ICN Biomedicals).
Statistical analysis
Analysis of variance was used to analyze data in Fig. 5. The t test was used
to analyze data in Figs. 6–9.
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